-
-
Sponsored By:
-
Sponsored By:
Source:
Flickr
3 Under-the-Radar Services Stocks With Upside Ahead
Accenture gets all of the attention in the consulting sector, but these three less-ballyhooed stocks are better bargain buys given their growth potential. Read
Have We Seen the Highs for the Summer?
Sam Collins predicts the market will turn lower, but hold at the support line of the bull channel. ReadThe 2013 Retirement Portfolio Candidates: Starbucks Stock
The king of coffee shops is in great shape, and has been for a few years. The stock is pricey, but might be right if you don't mind paying the premium. ReadDon't Panic About the Recent Turbulence
The Sell-in-May adage isn't an exact science. Let's look at the S&P 500 charts from the past decade for reassurance. ReadRecent Stories
-
Why Marijuana May Be the Next Diabetes Drug
-
Report: Google Faces New Antitrust Probe Over Ads
-
AT&T Is Charging Customers New Wireless Fee
-
America’s Biggest Retailers Sue Visa, MasterCard
-
McDonald’s Awards Charles Ramsey Free Food for a Year
-
Google Joins FB in Waze-Buyout Buzz
-
Xbox One: Ultimate Entertainment Console or Disaster?
-
Procter & Gamble Brings Back ‘Consumer Is Boss’ CEO
-
Gold Jumps as U.S. Dollar, Equities Slip
-
Stocks Shaky Amid China PMI Hit — Thursday’s IP Market Recap
Source:
Flickr
Sears Stock Still Is Screwed
Sears remains unprofitable, sales continue to decline and it keeps dipping into savings and tapping debt markets just to keep the lights on. Yeah, there's trouble.
Read
-
Gold Prices Are Tarnished for Good
-
Why Tumblr May Be Trouble for Yahoo
-
China, Japan and their Demographic Time Bombs
-
China PMI Hints Again at Hard Landing
Noodles & Co. Could Be a Tasty Offering
Multi-cuisine chain Noodles & Company has filed for a public offering in hopes of expanding its U.S. reach. Read
-
Q1 Earnings Preview: Can Workday Keep Killing It?
-
Don’t Move to SolarCity
-
NYSE Clubbing Nasdaq in the IPO Fight
-
Genomics Operator NanoString Technologies Files for an IPO
3 Pros & 3 Cons of Campbell Soup Stock
Campbell Soup Co. has pulled off a solid turnaround, as shown in its recent strong earnings report. Is it too late to get into the stock though? Read
-
Pandora Hits a High Note … But Don’t Join In
-
2 Stocks to Buy, 2 to Sell in Big Pharma
-
Utilities Crank Up the Income: 12 Companies Increasing Dividends
-
Yahoo’s Fire Will Stay Lit: The Ifs, Ands & Buts
IRS Official Refuses to Answer Congress
Lois Lerner, an IRS official, invoked her Fifth Amendment rights at a congressional hearing about the IRS treatment of conservative groups. Read
-
Anthony Weiner Will Run for NYC Mayor
-
Senator Vows to Repeal ‘Monsanto Protection Act’
-
Gov. Cuomo Threatens to Sue Kardashian Over T-Shirt
-
Supreme Court Will Hear Case On Disgruntled Frequent Flyer
PIMCO Does Active ETFs Right
Three new actively managed ETF versions of bond mutual funds co-managed by Bill Gross will be hitting markets soon. Given PIMCO's pedigree, these should be good. Read
-
What’s Your Exit Strategy?
-
Bad Weather Got Your Retailers Down? Bundle Up With an ETF
-
4 Lessons From 4 Crummy Mutual Funds
-
Gold Just Isn’t Worth the Risk
3 Dividend ETFs That Are Right for Retirement
These three ETFs offer solid income and capital gains potential. You can't ask for much more. Read
-
What Economists Can Teach Us About Investing
-
How to Choose a Financial Advisor
-
Rethinking the 4% ‘Golden Rule’
-
It’s Time to Stare Risk in the Face
Homebuilder on Verge of Double-Top Breakout
Toll Brothers' volume is accumulating and MACD just issued a buy signal. Get the target for TOL. Read
-
2 Ways to Play a Mending Apple
-
Nikkei: Aggressively Pulling Back, But Not Collapsing
-
An Opportunity Amid the Nikkei Crash
-
Let Yahoo Take Its Lumps for a Minute
The Alchemy of Printing Without Ink
Ben Bernanke has succeeded to do what alchemists for millennia could not accomplish: produce something out of nothing, using a controversial tool called QE. Read
-
Friday Apple Rumors: New iPhones to Come in Colors
-
McDonald’s CEO Gets a Talking-To by 9-Year-Old Food Activist
-
How College Grads Can Invest Without a Job
-
New Obesity Drug Could Launch in U.S. Before 2015
